Stock AFMD AFFIMED N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Affimed N.V.

Equities

AFMD

NL0015001ZQ0

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-24 pm EDT 		5-day change 1st Jan Change
4.19 USD -11.04% Intraday chart for Affimed N.V. -20.19% -32.96%
May. 23 Affimed Announces Positive Early Efficacy and Progression Free Survival Results of AFM24-102 Study in EGFR Wild-Type Non-Small Cell Lung Cancer at the Annual Meeting of the American Society of Clinical Oncology 2024 CI
Apr. 01 Wells Fargo Cuts Affimed Price Target to $25 From $30, Maintains Overweight Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
AFFIMED N.V.
Bio Therapeutic Drugs
-11.04%-20.19%-32.96%-52.03%-86.48% 63.8M
Bearish
Neutral
Neutral

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. AFMD Stock
  4. Charts Affimed N.V.
  5. Comparison Chart